Current Value
$7.501 Year Return
Current Value
$7.501 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PCRX | -36.29% | $1.15B | -14.20% | 0.00% |
AVD | -27.65% | $122.92M | -66.48% | 0.75% |
MITK | -23.72% | $376.43M | -40.10% | 0.00% |
PINC | -21.39% | $1.79B | -6.55% | 4.30% |
MRK | -19.17% | $218.76B | -33.33% | 3.60% |
CLX | -18.83% | $18.19B | +0.54% | 3.24% |
EL | -18.18% | $24.73B | -53.06% | 3.42% |
NFE | -18.11% | $2.35B | -71.65% | 1.37% |
CNC | -17.45% | $30.13B | -16.85% | 0.00% |
PUBM | -15.55% | $457.13M | -59.91% | 0.00% |
FIVN | -15.30% | $2.08B | -54.61% | 0.00% |
PYPL | -14.71% | $66.43B | +2.77% | 0.00% |
BDX | -14.59% | $65.01B | -7.05% | 1.80% |
RWAY | -14.57% | $390.65M | -13.26% | 14.91% |
AQN | -14.28% | $4.13B | -16.21% | 5.88% |
MOH | -13.97% | $17.97B | -13.21% | 0.00% |
FNA | -13.37% | $1.10B | +8.46% | 0.00% |
ATKR | -12.88% | $2.11B | -67.24% | 2.30% |
ADM | -12.28% | $23.03B | -23.43% | 4.19% |
REYN | -12.28% | $5.04B | -15.41% | 3.82% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -20.69% | $195.31M | 0.85% |
TAIL | -15.18% | $87.65M | 0.59% |
USDU | -14.40% | $206.96M | 0.5% |
BTAL | -12.65% | $416.76M | 1.43% |
UUP | -11.12% | $325.79M | 0.77% |
CARY | -9.58% | $347.36M | 0.8% |
IVOL | -8.95% | $476.36M | 1.02% |
XHLF | -8.63% | $1.06B | 0.03% |
FTSM | -8.45% | $6.38B | 0.45% |
BSCP | -7.82% | $3.63B | 0.1% |
BILS | -7.28% | $3.67B | 0.1356% |
KMLM | -7.17% | $218.49M | 0.9% |
XONE | -6.41% | $631.21M | 0.03% |
IBMP | -6.28% | $513.49M | 0.18% |
FTSL | -5.97% | $2.40B | 0.87% |
FMF | -5.92% | $154.59M | 0.95% |
DFNM | -5.87% | $1.51B | 0.17% |
SPTS | -5.83% | $5.97B | 0.03% |
IBTG | -5.79% | $1.82B | 0.07% |
CSHI | -5.55% | $523.02M | 0.38% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FXC | 27.76% | $68.21M | 0.4% |
PRNT | 24.92% | $73.21M | 0.66% |
ILF | 22.84% | $1.36B | 0.48% |
BBCA | 22.58% | $7.49B | 0.19% |
FLCA | 22.48% | $403.13M | 0.09% |
EWC | 22.25% | $2.62B | 0.5% |
IZRL | 22.23% | $94.93M | 0.49% |
CGBL | 21.81% | $1.87B | 0.33% |
UDEC | 21.48% | $328.38M | 0.79% |
GWX | 21.22% | $621.66M | 0.4% |
DFSI | 21.01% | $639.05M | 0.24% |
FRDM | 20.81% | $890.42M | 0.49% |
AVDV | 20.79% | $7.67B | 0.36% |
GNR | 20.75% | $2.74B | 0.4% |
DFIS | 20.69% | $2.63B | 0.39% |
EWD | 20.69% | $368.33M | 0.54% |
DISV | 20.60% | $2.55B | 0.42% |
CWI | 20.56% | $1.71B | 0.3% |
EPP | 20.54% | $1.85B | 0.48% |
MXI | 20.43% | $229.91M | 0.42% |
Yahoo
In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on earnings, an analyst initiation and patent issuance. EARNINGS: On Thursday, GH Research (GHRS) reported a FY24 loss per share of (75c), which compared to analyst estimates of loss per share of (80c). The company also reported cash, cash equivalents, other financial assets and marketable securities at $182.6M as of December 31, compared to cash, cash equivalents, other financial asset
Yahoo
Safety Review Committee Found No Safety Concerns Following Milestone Trial TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants.” A final safety review committee (“SRC”) mee
Yahoo
TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced it has retained the services of MZHCI, LLC, an MZ Group Company (“MZ”), to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ will work closely with Quan
Yahoo
TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced it has retained the services of Enterprise Canada Inc. (“Enterprise”) and Empire Market Ventures, LLC (“Empire”) (together, the “Agencies”) to lead its comprehensive public relations and investor awareness programs,
Yahoo
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that its licensee Celly Nutrition Corporation, the company behind unbuzzdTM – the scientifically-proven and game-changing beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms –a
Yahoo
SAN JOSE, Calif., February 04, 2025--Quantum® Corporation (NASDAQ: QMCO) ("Quantum" or the "Company"), a leader in solutions for AI and unstructured data, today announced it will release financial results for its fiscal third quarter 2025 on Wednesday, February 12, 2025, after the markets close.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FSIG | 0.02% | $1.27B | 0.55% |
CGCB | -0.03% | $2.01B | 0.27% |
USTB | 0.07% | $1.14B | 0.35% |
TBLL | -0.07% | $2.13B | 0.08% |
TFI | 0.09% | $3.29B | 0.23% |
BUXX | -0.09% | $234.79M | 0.25% |
STXT | -0.10% | $134.22M | 0.49% |
BSCR | -0.10% | $3.25B | 0.1% |
GRNB | -0.10% | $125.87M | 0.2% |
TFLO | 0.11% | $6.75B | 0.15% |
YLD | 0.14% | $300.27M | 0.39% |
IBMS | -0.19% | $46.94M | 0.18% |
BOND | 0.20% | $5.54B | 0.7% |
DBE | 0.20% | $55.52M | 0.77% |
DBO | -0.20% | $202.41M | 0.77% |
LONZ | 0.21% | $936.29M | 0.63% |
VCSH | -0.21% | $34.84B | 0.03% |
TUR | 0.22% | $185.31M | 0.59% |
IBTL | -0.24% | $361.53M | 0.07% |
TIP | 0.25% | $14.58B | 0.18% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XGN | 34.61% | $79.29M | +185.81% | 0.00% |
PLTR | 33.75% | $205.10B | +285.24% | 0.00% |
G | 32.66% | $8.88B | +57.41% | 1.30% |
CARG | 32.11% | $3.08B | +29.83% | 0.00% |
TBRG | 31.80% | $405.28M | +219.32% | 0.00% |
TBCH | 30.48% | $300.76M | -14.63% | 0.00% |
IOVA | 29.86% | $1.16B | -74.73% | 0.00% |
SLVM | 29.00% | $2.77B | +9.78% | 2.63% |
ADMA | 28.55% | $4.81B | +218.58% | 0.00% |
APPS | 27.95% | $310.82M | +28.70% | 0.00% |
HONE | 27.88% | $460.20M | +6.01% | 3.25% |
DOCN | 26.37% | $3.24B | -4.22% | 0.00% |
IAG | 26.34% | $3.72B | +77.26% | 0.00% |
DOCS | 25.53% | $10.87B | +125.49% | 0.00% |
AKAM | 25.49% | $12.28B | -23.77% | 0.00% |
ACLX | 25.47% | $3.69B | +6.38% | 0.00% |
AUDC | 25.46% | $284.93M | -23.93% | 4.04% |
ATSG | 25.31% | $1.48B | +71.04% | 0.00% |
SONO | 25.17% | $1.28B | -43.38% | 0.00% |
KREF | 24.98% | $729.86M | +6.54% | 9.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BDTX | 0.01% | $89.53M | -68.40% | 0.00% |
SYY | -0.01% | $36.84B | -5.82% | 2.69% |
PARAA | -0.01% | $15.13B | +2.22% | 0.89% |
EXAS | 0.02% | $8.28B | -38.81% | 0.00% |
BBW | -0.02% | $549.83M | +42.25% | 2.23% |
IAS | 0.02% | $1.32B | -19.98% | 0.00% |
GORV | 0.02% | $32.00M | -92.53% | 0.00% |
CDRE | 0.03% | $1.23B | -15.07% | 1.25% |
CODX | -0.04% | $12.02M | -68.04% | 0.00% |
IIIV | -0.04% | $588.52M | +12.39% | 0.00% |
KLXE | 0.04% | $59.35M | -57.27% | 0.00% |
IMXI | -0.05% | $399.09M | -42.89% | 0.00% |
BWA | 0.05% | $6.40B | -16.32% | 1.60% |
NTZ | -0.06% | $54.74M | -20.73% | 0.00% |
ES | 0.06% | $22.99B | +7.19% | 4.61% |
IRDM | -0.06% | $2.94B | +5.38% | 2.17% |
SEAT | -0.07% | $406.05M | -46.69% | 0.00% |
NOC | 0.07% | $74.14B | +12.07% | 1.60% |
CSTL | -0.07% | $575.70M | -6.22% | 0.00% |
ROKU | 0.08% | $10.43B | +14.79% | 0.00% |